FDA 483 - Michael Aman PhD - April 26, 2004
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Michael G. Aman, Ph.D., a clinical investigator at Ohio State University in Columbus, OH, revealed significant issues with research conduct. Observations included implementing changes to research activities without prior Institutional Review Board approval, failure to maintain accurate case histories with discrepancies in clinical data, and not conducting investigations in accordance with the approved investigational plan, specifically regarding the reporting of concomitant medications.
- Person
ID · ee4fa926-59e6-4850-9773-77fc33e0059f